or
forgot password
  • cancer clinical trials in massachusetts

  • Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    MetroWest Medical Center - Framingham Union Hospital

    Trial Locations
    MetroWest Medical Center - Framingham Union Hospital
    Cape Cod Hospital
    NSMC Cancer Center - Peabody
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care

    Trial Locations
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    UMASS Memorial Cancer Center - University Campus
    Leukemia
    Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Brain and Central Nervous System Tumors, Long-term Effects Secondary to Cancer Therapy in Children
    Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
    Beth Israel Deaconess Medical Center (Adult Site)

    Trial Locations
    Beth Israel Deaconess Medical Center (Adult Site)
    Children's Hospital of Boston (Pediatric Site)
    Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Tufts Medical Center
    Baystate Medical Center
    University of Massachusetts Memorial Health Care
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    Lymphoma
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Dana-Farber/Brigham and Women's Cancer Center
    Lahey Clinic Medical Center - Burlington
    Multiple Myeloma and Plasma Cell Neoplasm
    Scleroderma: Cyclophosphamide or Transplantation (SCOT)
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Scleroderma, Systemic, Sclerosis, Autoimmune Disease
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Sturdy Memorial Hospital

    Trial Locations
    Sturdy Memorial Hospital
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
    Dana-Farber/Brigham and Women's Cancer Center
    Addison Gilbert Hospital
    Cape Cod Hospital
    Lowell General Hospital
    UMASS Memorial Cancer Center - University Campus
    Breast Cancer
    Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
    UMASS Memorial Cancer Center - University Campus
    Worcester, Massachusetts 01605-2982
    Lymphoma
    Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Mantle Cell Lymphoma
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    Dana Faber Cancer Institute
    Boston, Massachusetts 02115
    Myeloid Leukemia, Chronic, Chronic-Phase
    Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
    Dana Faber Cancer Institute
    Boston, Massachusetts 02115
    Myeloid Leukemia, Chronic, Accelerated Phase, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
    Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Lowell General Hospital
    North Shore Medical Center Cancer Center
    South Shore Hospital
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Massachusetts General Hospital
    UMASS Memorial Cancer Center - University Campus
    Liver Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    University of Massachusetts Medical School
    Worcester, Massachusetts 01605
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Boston University Cancer Research Center

    Trial Locations
    Boston University Cancer Research Center
    Lahey Clinic Medical Center - Burlington
    MetroWest Medical Center - Framingham Union Hospital
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Metastatic Cancer, Prostate Cancer
    Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Non-Small-Cell Lung Carcinoma
    Avastin and Taxotere for Esophagogastric Cancer
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Esophageal Cancer, Gastric Cancer
    Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Adenocarcinoma, Non-small Cell Lung Cancer
    Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    Waldenstrom's Macroglobulinemia, Lymphoplasmacytic Lymphoma